Pain Management News
-
Showcase
Improve Your Wellbeing with Remedial Massage in Hobart City: How to Find the Right Therapist
Welcome to the definitive resource to improving your wellbeing with remedial massage in Hobart City! If you want to eliminate stress, ease tension, and improve your overall health, you’ve come to the correct place. In this blog post, we’ll look at the many benefits of remedial massage and offer helpful advice on how to select the right therapist for you. So sit back, relax, and ...
-
Histoplasmosis Infection Risks for Workers & Vulnerable Populations
ScienceNews published an article last year about the spread of three types of fungi that can cause serious lung diseases. One of these was Histoplasma which causes histoplasmosis, an infection once mainly found in the Midwest, but in more recent times infections have been recorded in at least 47 states. Histoplasma capsulatum lives in the environment, particularly in soil or other materials ...
-
CD Formulation Shows the Ability of Coated Microneedle Preparation Technology for Novel Drug Delivery
Advancements in drug delivery technology have paved the way for more efficient and targeted treatment options. Among these innovations is the development of coated microneedle preparation technology, which has shown promising results in delivering novel drugs to patients. CD formulation involves coated microneedles with specific drug compounds, allowing for controlled and sustained drug delivery. ...
-
Novel Drug Delivery System Unveiled: CD Formulation Launches Oral Thin Films Technology
In a groundbreaking development in the field of pharmaceuticals, CD Formulation, a prominent drug formulation company, has announced the launch of Oral Thin Film Technology. This cutting-edge drug delivery system is poised to revolutionize medication administration, offering patients a more convenient and effective treatment method. Oral Thin Film Technology is a user-friendly drug delivery ...
-
Microneedle Market Projected to Reach $1.3 Billion by 2028, Reveals Latest BCC Research Study
Boston: Microneedle technology, driven by high demand in dermatologic procedures and its versatile applications in drug delivery, vaccine administration, and disease diagnostics, faces challenges in its complex manufacturing process. Ongoing research and numerous products in development make this market dynamic for newcomers entering the field. “According to the latest BCC Research study, ...
By BCC Research
-
Synaptive’s Modus X Takes Center Stage in the latest issue of the Journal of Neurosurgery’s Neurosurgical Focus on exoscopes in neurosurgery
January’s Journal of Neurosurgery (JNS) published a series of 17 videos that examine the application of exoscopic visualization in cerebrovascular, neuro-oncologic, pediatric, peripheral nerve, and spinal neurosurgery. The video series highlights the exoscope as a versatile alternative to traditional optical microcopy. Seven of the videos highlight the use of Synaptive’s robotic ...
-
Caresyntax Future of Surgery Dinners: Where Excellence Meets Innovation
In the world of healthcare and innovation, where the qualitative and financial pressures are high and the challenges are complex, there exists a unique and exclusive gathering that is working to revolutionize the future of surgery. They are the Caresyntax Future of Surgery Dinners, and they are a unique format for bringing together leaders of health systems, med tech, surgery, insurance, and ...
By Caresyntax
-
Tris Pharma Presents Data Reinforcing Limited Abuse Potential of Investigational Pain Therapy Cebranopadol at the 2023 PAINWeek Conference
Positive results confirm findings from prior studies evaluating the abuse potential of cebranopadol, further highlighting its potential as a safe and potent alternative to traditional opioids Registrational phase 3 clinical trials of cebranopadol in moderate to severe acute pain are on track to initiate in Q4 2023 – Business Wire – Tris Pharma, Inc. (Tris), a commercial-stage ...
-
Histoplasma Infection Risks for Workers and Vulnerable Populations in Puerto Rico
Histoplasmosis is the name of an infection caused by a fungus known as Histoplasma capsulatum. The fungus lives in the environment, particularly in soil or other materials that contain large amounts of bird or bat droppings. Outbreaks of histoplasmosis have been recorded in Puerto Rico, as well as in the Dominican Republic and other parts of the Caribbean. The Centers for Disease Control and ...
-
New Offerings Released at Alfa Chemistry: Isoquinoline Alkaloids, Pyridine Alkaloids, and Phenylethylamine Alkaloids
Known for their extraordinarily antiparasitic, antiplasmodial, anticorrosive, antioxidative, antibacterial, anti-HIV, and insecticidal activities, alkaloids have found wonderful use in the pharmaceutical and medicinal filed as well as the human food and drink industry. To cater to the growing market demand for such type of chemicals, Alfa Chemistry recently announced a decision to open a new ...
-
Q-switched Nd:YAG laser for pigmented lesions
The Q switched Nd YAG laser tattoo removal machine is ideal for pigmented lesions such as nevus of Ota, all types of tattoos, eyebrow tattoos, eyeliner tattoos, pigmentation of foreign bodies on the skin and freckles and age spots. Bvlaser is a professional ND YAG laser machine manufacturer, we have Q switch ND:YAG laser melasma age pigment machine for sale. Principle of the Q-switched Nd:YAG ...
-
Tris Pharma Expands Leadership Team as Company Broadens Commercial Portfolio and Progresses Clinical Pipeline
Thomas Englese, a 20+ year industry veteran with a track record of success at leading biopharmaceutical companies, joins as chief commercial officer Marc Lesnick, Ph.D., appointed as chief development officer, bringing more than 20 years of experience in multiple therapeutic areas Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on ADHD, pain and neurological ...
-
With Policy Support, the Market for Surgical Robots Grows
Recently, the Ministry of Industry and Information Technology, the National Health Commission and other 17 departments jointly issued the "robot" application action implementation plan to encourage the development of surgery, auxiliary examination, auxiliary rounds, intensive care, rehabilitation and other medical robot products, "robot The "robot" has ushered in a new round of development ...
-
Is HIFU ultrasound treatment safe
Ultrasound HIFU beauty machine is a non-surgical skin tightening treatment, that uses medical aesthetic focused ultrasound technology to bypass the epidermis and heat the energy to 65-70°C and condense it into a large number of extremely fine hot spots. It is a one-time treatment with natural and progressive results that last from one to two years (results vary from person to person), with ...
-
Alertgy Awarded Patent US20200217809A1 Apparatus For In Vivo Dielectric Spectroscopy
Alertgy has been granted a patent for their innovative and groundbreaking radio frequency sensor technology. The awarded patent, Apparatus for in vivo dielectric spectroscopy (US20200217809A1), focuses on sensor technology that is 100% non-invasive and continuously monitors blood glucose in a way that does not involve blood oxidase, but rather dielectric spectroscopy and radio frequency. As a ...
By Alertgy
-
Meagan Medical Inc. Announces Issuance of a Key U.S. Patent for a Disruptive Chronic Pain Treatment using Spinal Cord Stimulation
Patent provides protection for High Frequency Spinal Cord Stimulation with Beat Technology Vancouver, Washington – March 20, 2015 – Meagan Medical Inc., a clinical research and medical device development company focused on investigating and developing optimal ways of managing and controlling pain, announced today the issuance of a key patent related to a unique ...
-
Targeting Alternative Opioid Receptor Reduces Drug Side Effects
A new study published in Proceedings of the National Academy of Sciences (PNAS) indicates, “Delta opioid receptors have a built-in mechanism for pain relief and can be precisely targeted with drug-delivering nanoparticles, making them a promising target for treating chronic inammatory pain with fewer side eects.” Researchers used cells from humans and mice with inammatory bowel ...
-
Leucine-Enkephalin as a Novel Analgesic: Efficacy and Safety in Pre-Clinical Models
Endogenous peptides with analgesic potential include endorphins via the mu receptor, dynorphins via the kappa receptor and enkephalins via the delta receptor. Kappa and delta opioid agonists have been shown to provide analgesic benefit while sparing toxic mu agonist toxicity1 . Preclinical data supports analgesia from enkephalin without significant opioid tolerance, or drug liking. Unfortunately, ...
-
Tris Pharma Reports Positive Topline Data from Clinical Study of Investigational Pain Therapy Cebranopadol Showing Significantly Less Potential for Abuse Versus Tramadol and Oxycodone
Study evaluating human abuse potential demonstrates that the likeability of cebranopadol administered orally in nondependent recreational opioid users was significantly less as compared to immediate release (IR) formulations of either tramadol or oxycodone, suggesting a lower potential for abuse versus traditional C-II and C-IV opioids A first-in-class investigational analgesic uniquely ...
-
MorphoSys Presents New Longer-term Phase 2 Results on Pelabresib in Myelofibrosis, Including Potential Disease-Modifying Activity, at ASH 2022
Data from the MANIFEST trial show durable improvements in both spleen volume and symptom score beyond 24 weeks with pelabresib in combination with ruxolitinib for JAK inhibitor-naïve patients An exploratory analysis of biomarkers from the MANIFEST trial indicates the potential for disease modification MorphoSys AG (FSE: MOR; NASDAQ: MOR) today announced results from analyses of the ...
By MorphoSys AG
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you